Skip to main content
. 2022 Aug 25;10(9):1394. doi: 10.3390/vaccines10091394

Table 3.

Quantification of nOPV2-c1_171 mutants in the virus-spiked samples by qmosRT-PCR assay using plasmids as reference standards.

Expected Mutant % (GC #) NGS (Set 1 and Set 2) qmosRT-PCR Runs-Mutant %
Set 1 of Spiked Samples Set 2 of Spiked Samples Average ± SD
Mutant % ± SD Run 1 Run 2 Run 3 Run 4 Run 5 Run 6
75.12 76.69 ± 0.27 89.68 81.88 80.04 89.98 89.42 89.96 86.83 ± 4.59
50.34 52.63 ± 2.25 68.42 53.02 54.33 69.74 68.30 69.08 63.81 ± 7.88
30.41 28.37 ± 0.59 41.17 31.03 32.49 49.39 47.39 49.81 41.88 ± 8.44
17.00 16.51 ± 1.08 22.07 13.31 14.46 28.88 27.00 32.27 23.00 ± 7.80
9.03 8.28 ± 0.02 10.25 6.94 7.63 14.37 13.09 15.99 11.38 ± 3.69
4.67 3.94 ± 0.26 2.56 2.36 2.27 5.47 4.86 7.49 4.17 ± 2.13
2.37 2.22 ± 0.35 0.28 0.55 0.42 1.24 1.07 1.68 0.87 ± 0.54
1.20 0.63 ± 0.21 0.01 0.12 0.07 0.16 0.13 0.34 0.14 ± 0.11
0.60 0.66 ± 0.29 ND 0.005 0.01 0.02 0.01 0.02 0.01 ± 0.01
0.30 0.42 ± 0.10 ND ND ND ND ND ND ND
0.15 ND ND ND ND ND ND ND ND

Note: GC #, genome copy number; NGS, next-generation sequencing (Illumina sequencing); SD, standard deviation; ND, not detected.